Neuromed Deal With Alza Will Accelerate Commercialization Strategy
This article was originally published in The Pink Sheet Daily
Executive Summary
Neuromed will develop a sales force to launch OROS hydromorphone in the U.S. in 2009 under a collaboration with the J&J subsidiary.